Liftstream is an executive search recruitment company in the life sciences sector
Loxo Oncology Expands Leadership Team
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Recruitment Market
Tagged Aisling Capital, biopharmaceutical, CFO, Cluster, Corporate Strategy, development, Dov Goldstein, Erivedge, EVP research & Development, executive recrutiment, Genentech, Jacob Van Naarden, Jennifer Low, Loxo Oncology, New York, research, USA, Vic President, Vicuron
Leave a comment
European biotech clusters must attract executive talent or seek new leaders
Authored by Karl Simpson
Posted in Job Hunting Advice, Pharmaceutical business
Tagged academics, Amsterdam Biotech, Bay Area Cluster, BioCat, Biopolis, BioRN, Biotech Clusters, biotechnology, bioValley, Boston Biotech, Bruce Booth, Cancer Bio-Sante, Chairman, commercial, development, Flanders Biotech, Industry, Katrine Bosley, London Biotech, Malaysia Biotech, Medical Devices, medical technology, Medicon Valley, Munich Biotech, New Zealand Biotech, non executive directors, One Nucleus, Oxford Biotech, pharmaceutical, research, Stevenage Biotech
Leave a comment
Biosimilars – is global development a reality?
Posted in Pharmaceutical business
Tagged animal studies, Biologicals Advice Limited, Biosimilar Medicines Working Party, biosimilars, CHMP, Committee for Advanced Therapies, Committee for Medicine Products for Human Use, comparator, development, Dr Narayanan, EMA, erythropoietin, europe, filgrastim, Gene Therapy Working Party, infliximab, regulatory affairs, somatropin
Leave a comment
UK aiming to boost regenerative medicine
Authored by James Sheppard
Posted in M&A Finance and Funding
Tagged cell sorter, Cell Therapy, commercialisation, David Willets, development, funding, London Biotech, One Nucleus, Oxford Biotech, regenerative medicine, research, science, Scottish Centre for Regenerative Medicine, stem cell research, Stevenage Biotech, UCL Institute of Ophthalmology, UK, UK government, UK Regenerative Medicine Platform, UKRMP
Leave a comment
Pharma’s emerging markets push creates talent gap
Liftstream looks at how the emerging markets is placing demands on talent and creating gaps in expertise within key functions like regulatory affairs.
Posted in General, Pharmaceutical business
Tagged Biogen IDEC, biotechnology, Brazil, BRIC, celgene, china, clinical, commercial, development, EMA, emerging markets, experience, FDA, G7, Gilead, global, India, N11, Orphan drugs, pharmaceuticals, regulatory affairs, Russia, Saudi Arabia, Shire, Singapore, skills, talent
Leave a comment